{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL7s_YYKDA","lastupdate":"2020-10-13T00:00:00.000Z","update_date":"2020-10-13T00:00:00.000Z","lastModified":"Feb 21, 2023","active":1,"confidence_score":92,"confidence_score_reason":"not claimed","urlname":"convergent-r-n-r","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$YJ9kTmTlMCNo65uUUc5pVYFD9rdZyluIjFGsCpsP27wVilMbcFvSSQ","name":"Convergent R.N.R.","oneliner":"X-ray Focusing for Cancer Treatment","registrar":"514498443","website":"https://convergent-rnr.com","careerspage":"","founded_month":9,"founded_year":2010,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCk8k-Bfe81KamoHZcF1qMIg","facebook":"https://www.facebook.com/mercybeam","linkedin":"https://www.linkedin.com/company/5087098","instagram":""},"social":["https://www.linkedin.com/company/5087098","https://www.youtube.com/channel/UCk8k-Bfe81KamoHZcF1qMIg","https://www.facebook.com/mercybeam"],"flattenedsociallinks":"https://www.linkedin.com/company/5087098|https://www.youtube.com/channel/UCk8k-Bfe81KamoHZcF1qMIg|https://www.facebook.com/mercybeam","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":17,"patent":1,"raised":3700000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["CRnR","Convergent RNR","mercybeam","Convergent Radiotherapy and Radiosurgery","mercy beam"],"about":"Convergent Radiotherapy and Radiosurgery is a medical start-up developing a new X-ray-focusing technology called MercyBeam. \r\n\r\nThe companys patented technology uses a standard imaging X-ray source to form a converging beam into a volume of treatment, rather than the standard diverging one. This development is designed to render radiotherapy treatment more accurate and safe and to spare healthy organs and cells.\r\n\r\nMercyBeam introduces a lens that collects most of the X-rays emanating divergently out of any standard X-ray tube and converges themtoward the tumors location. The lens simultaneously removes low-energy photons that would be absorbed by the patients skin. \r\n\r\nThe convergence increases the therapeutic dose delivered at the tumor location, while the organs in the vicinity of the tumor receive a very low dose or none at all. The converging technology enables the use of photon-energy X-rays 100 times lower than those used by current systems based on linear accelerators.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97237255961","country":null,"address":{"israeli":[{"id":"e89479cd-be6b-452b-98c7-86c54524b642","city":"Haifa","type":null,"address":"Andrei Sakharov St 9, Haifa, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"North District","news":[{"id":"e2879120-04dc-4077-b98a-1afa8120706b","date":"Jun 11, 2017","link":"https://www.newswise.com/articles/md-anderson-and-convergent-r-n-r-ltd-establish-alliance-to-further-develop-new-radiation-technology-with-potentially-fewer-side-effects2","source":"www.newswise.com","visible":1,"analysis":{"tags":["radiation technology","collaboration","clinical implementation","tumor-killing radiation"],"company":"The University of Texas MD Anderson Cancer Center","layoffs":null,"summary":"The University of Texas MD Anderson Cancer Center and Convergent R.N.R. Ltd. (CRnR) have announced a collaboration to develop new radiation technology aimed at reducing side effects of standard radiation. MD Anderson will work on enhancing and implementing CRnRs X-ray lens system called Mercy Beam™ to deliver tumor-killing radiation while limiting radiation to healthy organs. The study will focus on the systems use in treating head and neck, pediatric, and small tumors in various cancers. The collaboration will benefit CRnR by establishing it as a leader in treating small tumors and potentially speeding up development through preclinical and clinical trials. CRnR will develop an MLC-like collimator for MD Andersons assessment. MD Anderson will receive payments based on market capitalization, milestones toward FDA approval, and royalties for cancer treatments.","partners":["Convergent R.N.R. Ltd. (CRnR)"],"customers":null,"investors":null,"confidence":8,"key_topics":["radiation technology","collaboration","clinical implementation","tumor-killing radiation","cancer treatments"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Ak3ZDEbzo2lHS9jPxRGh667lhKi86NMtAbR2yNEYWg5CsxNX6Y3Hk7","news_summary":"MD Anderson and Convergent R.N.R. Ltd. Establish Alliance to Further Develop New Radiation Technology with Potentially Fewer Side Effects","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7d685146-7bac-4a52-9834-19182a553119","date":"Jul 31, 2014","link":"https://radiationtherapynews.com/2014/07/31/israeli-engineer-creates-lens-to-reduce-risks-of-radiation-therapy-in-children/","source":"radiationtherapynews.com","visible":1,"analysis":{"tags":"medical technology","company":"Convergent R.N.R.","layoffs":null,"summary":"An Israeli industrial engineer has developed a special lens called MercyBeam to improve radiation therapy, particularly for children. The lens collects three-dimensional X-rays and converges them directly onto a tumor, increasing the dosage in tumor cells while minimizing radiation to healthy tissue. The technology allows for the use of lower-energy X-rays, reducing the risks of radiation therapy in children. Convergent R.N.R. collaborated with top hospitals during development and received positive feedback. MercyBeam is expected to be more affordable than current systems, with a cost between $700,000 and $1 million. The company is seeking funding to build a prototype after receiving a grant of $700,000 from the Office of the Chief Scientist.","partners":null,"customers":null,"investors":["Office of the Chief Scientist"],"confidence":8,"key_topics":["radiation therapy","MercyBeam","X-ray technology","Convergent R.N.R.","limitations"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Vrx8VVcdMETYg1mGwgmQeCXQjrapCbO53izlx6rRkftAQDHt1facDV","news_summary":"Israeli Engineer Creates Lens to Reduce Risks of Radiation Therapy...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"355ddc32-85ce-4e92-8824-5a2d74dccb25","date":"Jul 16, 2014","link":"http://www.israel21c.org/radiation-therapy-is-about-to-get-much-kinder/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"radiation therapy","company":"Convergent RNR","layoffs":null,"summary":"Israeli company Convergent RNR has developed MercyBeam, a patented lens to improve radiation therapy for patients of all ages. The lens collects three-dimensional X-rays and converges them towards the tumor, increasing the therapeutic dose while minimizing exposure to surrounding tissue. MercyBeam is smaller, lighter, and less expensive than current radiation therapy systems, making it more accessible for clinics and hospitals. The company is collaborating with top hospitals and is in discussions with others to install the system. Convergent RNR is currently raising funds to build a prototype through conventional fundraising and a twist on crowdfunding called Contribute-Match-Donate. The company aims to reduce the price of the lens by growing the metal crystals themselves. Convergent RNR is headquartered in Tirat Carmel, Israel.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["MercyBeam","radiation therapy","X-ray technology","Convergent RNR","medical physicists"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"c9muC6ReFaxsjOiMSi5ozL70KGrJl3qmuXtWpIJITpmC8HLfdSzF5W","news_summary":"Radiation therapy is about to get much kinder","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fbf49674-76a4-4608-bc06-8d5256de001b","date":"Apr 2, 2014","link":"http://www.saferadiotherapy.com/convergent-rnr/","source":"www.saferadiotherapy.com","visible":1,"analysis":{"tags":"Web Hosting","company":"Bluehost.com","layoffs":"N/A","summary":"The article is a generic web hosting advertisement for Bluehost.com.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":10,"key_topics":["Affordable","Reliable"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"N/A","investment_amount":"N/A","structured_issues":[],"acquisition_amount":"N/A","entityGrowthIconPath":"none;"},"sentiment":"N/A","analysisId":"vFI3Fsahg1esKzENK1rzsKTwJQjdOsmy1c8fdDA1GWcpiBTb7i22E5","news_summary":"Welcome saferadiotherapy.com - BlueHost.com","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":4,"techcommunityinvolvement":null,"mediagallery":[{"id":"7da542bd-891d-46b6-a516-7d10c1d18861","timestamp":"2018-10-08 11:39:51.000000","resources_type":2,"resources_title":"Trailer","resources_file_name":"UEr3hcuM6Jg","alt":"Trailer logo","imageurl":"https://img.youtube.com/vi/UEr3hcuM6Jg/0.jpg","url":"http://youtu.be/UEr3hcuM6Jg"},{"id":"300360eb-dcab-4062-8357-e8e8cf8ad7d5","timestamp":"2014-12-15 09:48:04.000000","resources_type":2,"resources_title":"","resources_file_name":"xltOvraGxCM","alt":"","imageurl":"https://img.youtube.com/vi/xltOvraGxCM/0.jpg","url":"http://youtu.be/xltOvraGxCM"}],"tags":["medical-technologies","cancer","oncology","x-ray","lenses","radiology","babies","medical-devices","healthcare-providers","non-invasive","hospitals","children","patients","imaging","optronics","treatments","bioconvergence"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["MercyBeam"],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":1,"lastfunding":"$3M","totalrounds":2,"fundingstage":"Mature","totalfunding":"$3.7M","publicinvestors":1,"lastpublicfunding":3000000,"totalpublicrounds":2,"totalpublicfunding":3700000},"team":[{"name":"Ze'ev Harel","email":"zeev.h@convergent-rnr.com","phone":"0544555657","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgJ6Dq6wIDA","bounced":false,"claimed":0,"founder":1,"urlname":"ze-ev-harel","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDghLeN3wkM","position":"Co-founder & CEO","last_name":"Harel","claimtoken":"65e6ce3dc7f78f24a3d2ee7c9d3b190195c8905fbac1902caa268f3a790bfaa2","first_name":"Ze'ev","picturekey":"$USrHbYNeQkyWPVUtrLxO8Bs7dvUJ9DBex0OhKoStT5x6KsLCGHWVcN","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/zeevharel/","unsubscribed":false,"is_activeuser":0,"additionalemail":"zeev.b@convergent-rnr.com","claimedemaildate":"2020-10-13 06:22:28.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$USrHbYNeQkyWPVUtrLxO8Bs7dvUJ9DBex0OhKoStT5x6KsLCGHWVcN","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dr. Aharon Bar-David","email":"aralebd@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7HhasJDA","bounced":false,"claimed":1,"founder":1,"urlname":"dr-aharon-bar-david","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAvtrSgwsM","position":"Co-Founder & Chief physicist","last_name":"Bar-David","claimtoken":"4cf659702ed05bc55d7e50a51656f4c04ae14ed0464c2fe2db8bc1ca9bcf6a74","first_name":"Dr. Aharon","picturekey":"$EmCdkMAWCKQgdkeCBJj68jJnJmHeEIXRhnyg2CqDSoEA3YIy67r1mZ","claimeddate":"2014-12-15","linkedinurl":"https://www.linkedin.com/pub/dr-aharon-bar-david/17/896/907","unsubscribed":false,"is_activeuser":1,"additionalemail":"aharon.b@convergent-rnr.com","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$EmCdkMAWCKQgdkeCBJj68jJnJmHeEIXRhnyg2CqDSoEA3YIy67r1mZ","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Avigail Keller","email":"avigail.k@mercybeam.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN72r9AIDA","bounced":true,"claimed":0,"founder":1,"urlname":"avigail-keller","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsd-S5AgM","position":"Co-founder","last_name":"Keller","claimtoken":"7adc486da9bce640817633cd3dc317ae858b959eeebd3f03e5fdc8fe80f537d6","first_name":"Avigail","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/avigail-keller-71189051/","unsubscribed":false,"is_activeuser":0,"additionalemail":"avigail.k@convergent-rnr.com","claimedemaildate":"2020-10-13 06:22:16.000000","initials":"AK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Zeev  Burshtein","email":"zeevb@mercybeam.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4LiDq6UKDA","bounced":true,"claimed":0,"founder":1,"urlname":"zeev-burshtein","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg2OuQgQoM","position":"Co-founder","last_name":"Burshtein","claimtoken":"c510b4c583fe06689c7c52db31d0828fc06d5d485c4fad624aa69a4608aeba51","first_name":"Zeev ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/zeev-burshtein-88943b91/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-10-13 06:22:21.000000","initials":"ZB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7UwIEIDA","fullname":"Aviv Alper"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2020-01-13T00:00:00.000Z","crunchbaseid":"convergent-rnr","lastupdator":"Orli Wollner","lastupdator_email":"orlushka@gmail.com","creator":null,"creator_email":null,"createdate":"2014-12-15T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Aviv Alper","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2uWoCgw","date":"Dec 2017","amount":"$3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjcWWCQw","date":"","amount":"$700K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Office of the Chief Scientist","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/office-of-the-chief-scientist","logokey":null,"tagline":"","urlname":"/investor_page/office-of-the-chief-scientist","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEv8qRCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6d63e3e5-9ad2-4a1f-8037-3db60e4a2a8b","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"9/2010","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Convergent R.N.R.","logourl":"https://storage.googleapis.com/clean-finder-353810/$YJ9kTmTlMCNo65uUUc5pVYFD9rdZyluIjFGsCpsP27wVilMbcFvSSQ","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$YJ9kTmTlMCNo65uUUc5pVYFD9rdZyluIjFGsCpsP27wVilMbcFvSSQ","seoabout":"Convergent Radiotherapy and Radiosurgery is a medical start-up developing a new X-ray-focusing technology called MercyBeam. \r\n\r\nThe companys patented techn...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","TechnologyClassificationModel>Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"},{"title":"Providers","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Simulation & Imaging","key":"0-0","path":"TechnologyClassificationModel>Simulation & Imaging"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Simulation & Imaging"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Patients","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2uWoCgw","date":"Dec 2017","amount":"$3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjcWWCQw","date":"","amount":"$700K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Office of the Chief Scientist","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/office-of-the-chief-scientist","logokey":null,"tagline":"","urlname":"/investor_page/office-of-the-chief-scientist","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEv8qRCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6d63e3e5-9ad2-4a1f-8037-3db60e4a2a8b","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}